Long-term patients operated and treated for alveolar echinococcosis;Devenir à long terme des malades opérés et traités pour échinococcose alvéolaire

Annales de Chirurgie

Volumn 129, Issue 6-7, 2004, Pages 337-342

  Charbonnet, P ^a   Buhler L ^a   Sagnak, E ^a   Villiger, P ^a   Morel, P ^a   Mentha, G ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alveolar echinococcosis; Benzimidazole chemotherapy; D riv s benzimidazol s; chinococcose alv olaire; H patectomie; Hepatectomy

Indexed keywords

BENZIMIDAZOLE;

ADULT; ARTICLE; BILE DUCT FISTULA; BILOMA; CHOLANGITIS; CLINICAL ARTICLE; DIAPHRAGM; DISEASE COURSE; EXPERIENCE; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; LIVER HYDATID CYST; LIVER LOBECTOMY; LIVER TRANSPLANTATION; MALE; NECROSIS; PLEURA; SURGICAL DRAINAGE; TREATMENT OUTCOME;

ADULT; AGED; ANTHELMINTICS; BENZIMIDAZOLES; ECHINOCOCCOSIS, HEPATIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 4043162117     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anchir.2004.01.017     Document Type: Article

References (26)

1. Buttenschoen K., Schorcht P., Reuter S., et al. Die chirurgische Therapie der alveolären Echinokokkose und deren Langzeitergebnisse. Chirurg. 72:2001;566-572
2. Ammann R.W., Fleiner Hoffmann A., Eckert J., et al. Schweizerische Studie für Chemotherapie der alveolären Echinokokkose-Rückblick auf ein 20jähriges klinisches Forschungsprojekt. Schweiz Med Wochenschr. 129:1999;323-332
3. Jenne L., Kilwinski J., Radloff P., et al. Clinical Efficacy of and Immunologic Alterations Caused by Interferon gamma Therapy for Alveolar Echinococcosis. Clinical infectious Diseases. 26:1998;492-494
4. Craig P.S., Deshan L., Mac Pherson C.N., Dazhong S., Reynolds D., Barnish G., et al. A large focus of alveolar echinococcosis in central China. Lancet. 340:1992;826-831
5. Rausch R.L., Wilson J.F., Schantz P.M. A program to reduce the risk of infection of Echinococcus multilocularis : the use of praziquantel to control the cestode in a village in the hyperendemic region of Alaska. Ann. Trop. Med. Parasitol. 84:1990;239-250
6. Martinek K., Kolarova L., Hapl E., Uhrin M. Echinococcus multilocularis in European wolves (Canis lupus). Parasitol Res. 87:2001;838-839
7. Hofer S., Gloor S., Müller U., Mathis A., Hegglin D., Deplazes P. High prevalence of Echinococcus multilocularis in urban red foxes (Vulpes vulpes) and voles (Arvicola terrestris) in the city of Zürich, Switzerland. Parasitology. 120:2000;135-142
8. Heyd B., Weise L., Bettschart V., Gillet M. Chirurgische Therapie beim Echinococcus alveolaris der Leber. Chirurg. 71:2000;16-20
9. Bresson-Hadni S., Mantion G.A. Que reste-t-il du traitement chirurgical de l'échinococcose alvéolaire ? La Lettre de l'hépato- gastroentérologue. Vo:(3):2002;118-123
10. Juan Dai W., Hemphill A., Waldvogel A., et al. Major Carbohydrate Antigen of Echinococcus multilocularis Induces an Immunoglobulin G Response independent of αβ+ CD4+ T Cells. Infection and Immunity. 69:2001;6074-6083
11. Guerret S., Vuitton D.A., Liance M., et al. Echinococcus multilocularis : relationship between susceptibility/resistance and liver fibrogenesis in experimental mice. Parasitol Res. 84:1998;657-667
12. Ammann R.W., Eckert J. Cestodes, Echinococcus. Gastroenterol Clin N Am. 25:1996;655-689
13. Ammann R.W. Mortality and morbidity in 104 patients with alveolar echinococcosis in the Swiss chemotherapy trial (1976-1994). Uchino J., Sato N. Alveolar echinococcosis, strategy for eradication of alveolar echinococcosis of the liver. 1996;283-292 Fuji Shoin, Sapporo, Japan
14. Ammann R.W., Ilitsch N., Marincek B., Freiburghaus A.U. the Swiss Echinococcosis Study Group. Effect of Chemotherapy on the Larval Mass and the Long-term Course of Alveolar Echinococcosis. Hepatology. 19:1994;735-742
15. Gottstein B. Epidemiologie und systematik der cystischen und alveolären Echinokokkose. Chirurg. 71:2000;1-8
16. Bähr R., Gaebel G. Chirurgische Therapie der Lebenechinokokkose. Zentralbl Chir. 110:1995;524-531
17. B. Gottstein, B. Mesarina, I. Tanner, et al. Specific cellular and humoral immune responses in patients with different long term courses of alveolar echinococcosis. Am J trop Med Hyg, 45: 734-742.
18. Gottstein B., Schantz P.M., Wilson J.F. Serological screening of Echinococcus multilocularis infections with Elisa. Lancet I. 11:1985;1097-1098
19. Mboti B., Van de Stadt J., Carlier Y., et al. Long-term disease-free survival after liver transplantation for alveolar echinococcosis. Acta Chir Belg. 1996;229-232
20. Koch S., Bresson-Hadni S., Miguet J.P., Kurtz S., et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45 case european collaborative report. Transplantation. 75:2003;856-863
21. Bresson-Hadni S., Koch S., Beurton I., et al. Primary Disease Recurrence After Liver Transplantation for Alveolar Echinococcosis: Long-Term Evaluation in 15 Patients. Hepatology. 30:1999;857-864
22. Bresson-Hadri S., Franza A., Miguet J.P., et al. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases. Hepatology. 13:1991;1061-1070
23. Suter M., Gillet M. Liver Transplantation in Alveolar Hydatid Disease. Dig Surg. 14:1997;229-234
24. Mosimann F. Is Alveolar Hydatid Disease of the Liver Incurable? Ann Surg. 192:1980;118-123
25. informal Working Group on Echinococcosis W.H.O. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Organ. 74:1996;231-242
26. Stieger C., Hegglin D., Schwarzenbach G., Mathis A., Deplazes P. Spatial and temporal aspects of urban transmission of Echinococcus multilocularis. Parasitology. 124:2002;631-640